Results 181 to 189 of about 1,183,314 (189)

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

Cancer Medicine, 2013
Cameron Snell, Adrian L Harris, Francesco Pezzella   +2 more
exaly  

HIV‐positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study

Journal of the International AIDS Society, 2016
Leila Katirayi, Thorkild Tylleskär, Paola Triggianese   +2 more
exaly  

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Nature Medicine, 2016
Xianming Tan, Peter Vermeulen, Zu-hua Gao   +2 more
exaly  

Parametric Inference and Dynamic State Recovery From Option Panels

Econometrica, 2015
Viktor Todorov
exaly  

Firm heterogeneity in growth option value: The role of managerial incentives

Strategic Management Journal, 2012
Tony W Tong
exaly  

Combined Pricing and Portfolio Option Procurement

Production and Operations Management, 2012
Sean X Zhou, Xiuli Chao, S V Eremeev
exaly  

Factors associated with retention in Option B+ in Malawi: a case control study

Journal of the International AIDS Society, 2017
Risa M Hoffman, David Elashoff, Paul Kawale   +2 more
exaly  

The assignment of call option rights between partners in international joint ventures

Strategic Management Journal, 2013
Sali Li, Tony W Tong
exaly  

Denosumab an option for patients with bone metastasis from breast cancer

Ca-A Cancer Journal for Clinicians, 2011
exaly